Trademark Overview
On Monday, March 31, 2025, a trademark application was filed for BHYLOR with the United States Patent and Trademark Office. The USPTO has given the BHYLOR trademark a serial number of 99112415. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, March 31, 2025. This trademark is owned by Mineralys Therapeutics, Inc.. The BHYLOR trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention and treatment of hypertension, sleep apnea, chronic kidney disease, heart failure, primary aldosteronism, myocardial infarction, coronary artery disease, blood vessel wall thickening, renal fibrosis, nephropathy, and vascular dementia